Status:
COMPLETED
Imaging the Dopamine Systems in Bulimia Nervosa
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Eating Disorders
Eligibility:
FEMALE
18-45 years
Brief Summary
This study will use positron emission tomography imaging to investigate the dopamine systems in people with bulimia nervosa.
Eligibility Criteria
Inclusion
- Participants with BN:
- Meets DSM-IV criteria for BN
- Sufficiently medically and psychiatrically stable to participate in research
- Health Control Participants:
- No current or past psychiatric illness
- Between 80% and 120% of ideal body weight
Exclusion
- All participants:
- Current use of psychotropic medication such as anti psychotics or antidepressants
- Pregnant or breastfeeding
- history of substance abuse
- Significant medical illness
- High blood pressure (resting systolic blood pressure greater than 150mmHg and diastolic blood pressure greater that 90 mmHg)
- Current or lifetime history of schizophrenia, bipolar disorder, or other psychotic disorder as defined by DSM-IV
- Metal implants or paramagnetic objects contained within the body that may interfere with the MRI scan, as determined in consultation with a neuroradiologist and according to specified reference book guidelines
- Exposed to radiation in the workplace or has had a nuclear medicine procedure during the 1 year before study entry
- Previous adverse reaction to psycho stimulants
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT01493362
Start Date
January 1 2008
End Date
December 1 2013
Last Update
August 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032